IRIS Institutional Research Information System - OPENBS Open Archive UniBS

LAPADULA, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.553
EU - Europa 478
AS - Asia 403
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 2.438
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.545
CN - Cina 233
UA - Ucraina 140
DE - Germania 113
SG - Singapore 76
GB - Regno Unito 64
FI - Finlandia 61
HK - Hong Kong 50
IT - Italia 25
RU - Federazione Russa 24
IE - Irlanda 23
TR - Turchia 22
FR - Francia 19
IR - Iran 10
IN - India 9
CA - Canada 8
BE - Belgio 4
AU - Australia 2
EU - Europa 2
JP - Giappone 2
LT - Lituania 2
SE - Svezia 2
AL - Albania 1
KZ - Kazakistan 1
Totale 2.438
Salva come PNG Salva come JPEG
Città #
Woodbridge 218
Fairfield 204
Ann Arbor 131
Ashburn 118
Houston 116
Jacksonville 116
Chandler 102
Cambridge 77
Seattle 73
Wilmington 71
Singapore 59
Hong Kong 50
Nanjing 49
Beijing 43
Helsinki 42
Princeton 42
Lancaster 36
Dublin 23
New York 22
Istanbul 21
Los Angeles 19
Shanghai 18
Nanchang 17
Jinan 15
Shenyang 15
Tianjin 14
Changsha 13
Des Moines 12
San Diego 12
Moscow 11
Ardabil 10
Hebei 9
Milan 9
Munich 7
Toronto 7
Dearborn 6
Kunming 6
Washington 6
Hangzhou 5
Ningbo 5
Augusta 4
Brussels 4
Frankfurt am Main 4
Lanzhou 4
Monmouth Junction 4
Brescia 3
Guangzhou 3
Haikou 3
London 3
San Francisco 3
Taiyuan 3
Fuzhou 2
Jiaxing 2
Leawood 2
Phoenix 2
Taizhou 2
Verona 2
Canberra 1
Changchun 1
Clifton 1
Cologno Al Serio 1
Como 1
Dallas 1
Falkenstein 1
Gunzenhausen 1
Hanover 1
Krasnoyarsk 1
Monza 1
Nürnberg 1
Oklahoma City 1
Orange 1
Ottawa 1
Pune 1
Redwood City 1
Rende 1
Santa Clara 1
Sydney 1
Tirana 1
Tokyo 1
Totale 1.901
Salva come PNG Salva come JPEG
Nome #
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 197
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 142
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients. 124
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naive for lopinavir with limited exposure to previous protease inhibitors. 123
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients. 123
Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: predictors of virological response and drug resistance evolution in a multi-cohort study. 122
Dideoxynucleoside HIV reverse transcriptase inhibitors and drug-related hepatotoxicity: a case report. 121
Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART. 113
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: a cross-sectional study 112
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. 110
Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications. 110
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy. 107
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 107
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 105
Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis. 102
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts 93
Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients. 83
Plasma HIV load and proviral DNA decreases after two standard antiretroviral regimens in HIV-positive patients naïve to antiretrovirals 80
Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy. 76
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort. 72
Predictors of AIDS-defining events among advanced naïve patients after HAART. 65
Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3. 64
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy 54
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 51
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 9
Totale 2.465
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.515
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020385 0 0 0 0 0 61 66 66 65 84 8 35
2020/2021321 5 35 7 39 12 53 14 38 47 27 30 14
2021/2022221 34 21 5 10 0 12 7 16 5 30 22 59
2022/2023247 23 5 6 14 25 61 0 29 56 1 10 17
2023/2024245 11 7 25 32 12 48 13 6 55 13 4 19
2024/2025162 8 6 1 68 54 25 0 0 0 0 0 0
Totale 2.465